| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 09/19/2000 | CA2046188C Kit for the specific assay of angiotensin ii |
| 09/14/2000 | WO2000053740A1 Method for screening biomolecule activity regulator |
| 09/14/2000 | WO2000053627A1 METHOD FOR PRODUCING CYCLO-(Asp-DPhe-NMeVal-Arg-Gly) |
| 09/14/2000 | WO2000053626A1 Peptide having an antitumoral, protection and normalisation activity and pharmaceutical composition |
| 09/14/2000 | WO2000053621A2 Synthetic complementary peptides and ophthalmologic uses thereof |
| 09/14/2000 | WO2000053189A1 Inhibitors of calcium influx factor synthesis and/or action and uses thereof |
| 09/14/2000 | WO2000024913A3 Mn gene and protein |
| 09/14/2000 | WO2000022129A9 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 09/14/2000 | WO2000011032A3 Method for producing biostatin (tt-232 triacetate) and analogs thereof |
| 09/14/2000 | WO1999063999A8 H1-histamine receptor antagonists |
| 09/14/2000 | CA2367313A1 Method for screening biomolecule activity regulator |
| 09/14/2000 | CA2366678A1 Synthetic complementary peptides and ophthalmologic uses thereof |
| 09/13/2000 | EP1035133A2 Fusion proteins comprising carriers that can induce a dual immune response |
| 09/13/2000 | EP1034785A2 Hepatitis C virus diagnostics and vaccines |
| 09/13/2000 | EP1034431A2 Method of detecting prostate specific antigen activation peptide |
| 09/13/2000 | EP1034182A1 Inhibition of nuclear import by backbone cyclic peptide analogs |
| 09/13/2000 | EP0759941B1 Heterodimer polypeptideimmunogen carrier composition and method for their use |
| 09/13/2000 | EP0674652B1 Dolastatin analog |
| 09/13/2000 | CN1266459A Method and reagents for vaccination which generate a CD8 T cell immune response |
| 09/13/2000 | CN1056381C Active peptide for promoting immunization function and usage thereof |
| 09/12/2000 | US6117974 For screening bioactive molecules; compounds have n-alpha derivative amino acids linked by bridging group of disulfide, amide, thioether, thioester, imine, ether, or alkene to terminus located at a side chain or a backbone nitrogen |
| 09/12/2000 | US6117896 Methods for regulating transcription factors |
| 09/12/2000 | US6117840 Inhibits binding between vla-4 receptor expressed on inflammatory leukocytes and fibronectin cs-1 peptide expressed on endothelial cells that are involved in immunoinflammatory disease states |
| 09/12/2000 | US6117645 Human LH-RH receptor expression cells and use thereof |
| 09/12/2000 | US6117421 Method for promoting cell growth and immunosuppression using chaperonin |
| 09/08/2000 | WO2000052051A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 09/08/2000 | WO2000052048A1 Modulators of beta-amyloid peptide aggregation comprising d-amino acids |
| 09/08/2000 | WO2000052037A1 Echinocandin/carbohydrate complexes |
| 09/08/2000 | WO2000052036A1 Formation and anion-exchange of crystalline echinocandin ammonium salts |
| 09/08/2000 | WO2000035407A3 Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs |
| 09/08/2000 | CA2362826A1 Formation and anion-exchange of crystalline echinocandin ammonium salts |
| 09/08/2000 | CA2362016A1 Echinocandin/carbohydrate complexes |
| 09/06/2000 | EP1033372A1 Compounds with antitumor activity |
| 09/06/2000 | EP1032708A1 Nucleic acid ligands of tissue target |
| 09/06/2000 | EP1032588A1 Interaction of alpha-conotoxin peptides with neuronal nicotinic acetylcholine receptors |
| 09/06/2000 | EP1032587A1 Novel exendin agonist compounds |
| 09/06/2000 | EP1032586A1 Hypusine peptides |
| 09/06/2000 | EP1032585A1 Deoxyhypusine reagent and peptides |
| 09/06/2000 | EP1032422A1 Linear antigen supporting units |
| 09/06/2000 | EP1032420A1 Immunoglobulin molecules having a synthetic variable region and modified specificity |
| 09/06/2000 | EP0882066B1 Peptide derivatives |
| 09/06/2000 | EP0641222B1 TECHNETIUM-99m LABELED PEPTIDES FOR THROMBUS IMAGING |
| 09/06/2000 | EP0631502B1 Lymphocyte activity regulation by hla peptides |
| 09/06/2000 | CN1056153C Peptide inhibitors of mitogenesis and motorgenesis |
| 09/05/2000 | US6114516 Nucleotide sequences coding for variable regions of the αchains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic muses |
| 09/05/2000 | US6114160 Polynucleotide which codes for polypeptide of defined amino acid sequence which has taxadiene synthase activity; for recombinant production especially higher than normal gene expression in escherichia coli |
| 09/05/2000 | US6113902 Polypeptides with amino acid sequences of pro-lys-ile and cyclic epitopes |
| 09/05/2000 | US6113899 Antagonists of chaperonin 10 |
| 09/05/2000 | US6113878 Scintigraphy |
| 08/31/2000 | WO2000050460A1 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses |
| 08/31/2000 | WO2000050447A1 Carbohydrate epitope mimic peptides and uses thereof |
| 08/31/2000 | WO2000018795A9 Compositions and methods for wt1 specific immunotherapy |
| 08/31/2000 | CA2363637A1 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses |
| 08/31/2000 | CA2363601A1 Carbohydrate epitope mimic peptides and uses thereof |
| 08/30/2000 | EP1030684A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response |
| 08/30/2000 | EP1030679A1 Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
| 08/30/2000 | EP0759937B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 08/30/2000 | EP0705274B1 Method and composition for treating thrombosis |
| 08/30/2000 | EP0671946B1 Immunoreactive peptides from epstein-barr virus |
| 08/30/2000 | EP0584290B1 Endothelin antagonists |
| 08/29/2000 | US6111089 Nucleic acid encoding a defined mouse amino acid sequence of a protein involved in embryo implantation; vaccine can be used as antifertility agent |
| 08/29/2000 | US6111067 Bactericides against grampositive bacteria |
| 08/29/2000 | US6111065 Inhibit neutrophil adhesion to p-selectin; antiinflammatory agents; anticoagulants; diagnostics |
| 08/29/2000 | US6110895 Method of promoting healing in skin grafts |
| 08/29/2000 | US6110889 Administering hexapeptides of amino acid sequence arg-arg-trp-trp-cys-arg to inhibit alpha-chemokine binding to the tumor cell |
| 08/29/2000 | US6110747 Compounds and methods for modulating tissue permeability |
| 08/29/2000 | US6110694 Methods for determining complexes of tumor rejection antigens and HLA-Cw*160/molecules |
| 08/29/2000 | US6110467 Isolated porcine respiratory and reproductive virus, vaccines and methods of protecting a pig against a disease caused by a porcine respiratory and reproductive virus |
| 08/24/2000 | WO2000048620A1 Yeast cell wall peptides and antibodies thereto |
| 08/24/2000 | WO2000048464A1 Ng2/hm proteoglycan-binding peptides that home to angiogenic vasculature and related methods |
| 08/24/2000 | WO2000021987A9 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease |
| 08/24/2000 | WO2000018440A8 Somatostatin receptor radioligand with increased uptake |
| 08/24/2000 | WO1998000439A3 Multivalent compounds for cross-linking receptors and uses thereof |
| 08/24/2000 | CA2371799A1 Yeast cell wall peptides and antibodies thereto |
| 08/23/2000 | EP1029869A1 Endothelin converting enzyme inhibitors |
| 08/23/2000 | EP1028977A2 Bifidus stimulating peptides |
| 08/23/2000 | EP1028971A2 Novel conjugates of rgd-containing peptides and endogenous carriers |
| 08/23/2000 | EP0861228B1 Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 08/23/2000 | EP0584247B1 Compositons for the treatment of chronic fatigue syndrome |
| 08/23/2000 | CN1264388A Dolastatin 15 derivatives |
| 08/23/2000 | CN1055700C Therapeutic peptide derivatives |
| 08/22/2000 | US6107469 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody |
| 08/22/2000 | US6107458 Cyclic hexapeptides having antibiotic activity |
| 08/22/2000 | US6107293 Analgesics |
| 08/22/2000 | US6107275 Anticoagulants |
| 08/22/2000 | US6107271 Neuroactive peptides |
| 08/22/2000 | US6107104 Calcineurin deletion mutant which binds a-kinase anchor protein 79 and having defined amino acid sequence; for screening enzyme inhibitors for use as immunosuppressants with reduced side effects |
| 08/22/2000 | US6106844 Administering to venom allergic patient |
| 08/22/2000 | CA2056381C Cysteine thiol-protected peptides for use in immunoassays |
| 08/22/2000 | CA2050343C Matrix metalloproteinase peptides: role in diagnosis and therapy |
| 08/22/2000 | CA2046900C Melanin-concentrating hormones and methods of treatment using same |
| 08/17/2000 | WO2000047775A1 Selection of proteins using rna-protein fusions |
| 08/17/2000 | WO2000047736A1 Polypeptide variants with raised heparin-binding capacity |
| 08/17/2000 | WO2000047618A2 HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES |
| 08/17/2000 | WO2000047609A1 Cyclic peptides and aids vaccines |
| 08/17/2000 | WO2000047607A1 A synthetic peptide disturbing intracellular signaling |
| 08/17/2000 | WO2000047548A1 Improved compounds for protein binding |
| 08/17/2000 | WO2000047228A1 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies |
| 08/17/2000 | WO2000047221A1 Antiangiogenic drugs |
| 08/17/2000 | WO2000047220A1 Controlling protein levels in eucaryotic organisms |